Skip to main content

Codexis, Inc. (CDXS) Stock Forecast

Data as of May 2, 2026

Healthcare · Current price $2.67 (-5.14%)

Consensus Target
$5.00
Upside
+86.9%
Analysts
Rating

Price Target Range

Low $5.00High $5.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Mar 12, 2026Daniel AriasStifel Nicolaus$5.00+86.9%
May 30, 2024Kristen KluskaCantor Fitzgerald$11.00+311.2%

CDXS vs Sector & Market

MetricCDXSHealthcare AvgLarge Cap Avg
Analyst Rating2.242.41
Analyst Count818
Target Upside+86.9%+1150.2%+14.9%
P/E Ratio-5.806.8731.19

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$15M$17M$19M4
2026-09-30$18M$19M$21M2
2026-12-31$23M$24M$26M3
2027-03-31$16M$17M$19M3
2027-06-30$17M$19M$20M2
2027-09-30$20M$22M$24M2
2027-12-31$25M$27M$29M3
2028-12-31$86M$92M$106M3
2029-12-31$90M$97M$111M2
2030-12-31$109M$118M$135M1

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$-0.19$-0.12$-0.052
2026-09-30$-0.12$-0.10$-0.091
2026-12-31$-0.08$-0.07$-0.061
2027-03-31$-0.10$-0.09$-0.081
2027-06-30$-0.09$-0.08$-0.071
2027-09-30$-0.08$-0.07$-0.071
2027-12-31$-0.07$-0.07$-0.061
2028-12-31$-1.32$-0.26$0.802
2029-12-31$-0.36$-0.30$-0.271
2030-12-31$-0.29$-0.24$-0.221

Frequently Asked Questions

What is the analyst consensus for CDXS?

The consensus among 0 analysts covering Codexis, Inc. (CDXS) is — with an average price target of $5.00.

What is the highest price target for CDXS?

The highest price target for CDXS is $11.00, set by Kristen Kluska at Cantor Fitzgerald on 2024-05-30.

What is the lowest price target for CDXS?

The lowest price target for CDXS is $5.00, set by Daniel Arias at Stifel Nicolaus on 2026-03-12.

How many analysts cover CDXS?

0 analysts have issued ratings for Codexis, Inc. in the past 12 months.

Is CDXS a buy or sell right now?

Based on 0 analyst ratings, CDXS has a consensus rating of — with a +86.9% upside to the consensus target of $5.00.

What are the earnings estimates for CDXS?

Analysts estimate CDXS will report EPS of $-0.12 for the period ending 2026-06-30, with revenue estimated at $17M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.